Stephen Quinn is the CEO and Managing Director of Ratner Biomedical Group (RBG), an intellectual property firm dedicated to the fields of biocompatible materials, tissue engineering and drug delivery. At RBG, Mr. Quinn has formed a board of science advisors to facilitate the exchange of ideas, knowledge and experience with other frontrunners in the biomedical field. He serves on the biotech screening committee for Alliance of Angels, giving him a unique perspective and edge on understanding cutting edge life science technologies with potential.

Mr. Quinn co-founded Portfolio Effect, LLC, a Puget Sound-based private equity partnership in 2004, and was resident as an employee when three different technology startups as they went through the IPO process. Mr. Quinn has nearly 20 years' experience in the technology industry, at companies ranging from Adobe to Claris, including 8 years in managerial roles at Microsoft.

Having a strong technology writing, testing and planning background, Mr. Quinn built and lead teams of software testers on OLAP, Data Mining and other projects, While at Microsoft, he was leader of tools development for testing in the Natural Language Group.

Using his skills learned across the software industry, Mr. Quinn has written several publications, including the book Professional SQL Server Analysis Services 2005 Using MDX (with Siva Harinath), the article Testing, Testing (with Muralidhar Sitaram) and other feature articles in Datamation and InfoWorld magazines.

Mr. Quinn has a Master's degree in Cognitive Psychology from California State University, Chico, and also has an MBA from the University of Washington in Seattle.